Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial

被引:0
|
作者
Patel, S. [1 ]
Unger, J. M. [2 ]
Othus, M. [2 ]
Darke, A. [2 ,3 ]
Tarhini, A. A.
Kirkwood, J. M. [4 ]
Sharon, E. [5 ]
Sondak, V. [3 ]
Ribas, A. [6 ]
Grossmann, K. F. [7 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Melanoma Med Oncol, Houston, TX 77030 USA
[2] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol, Tampa, FL USA
[4] UPMC Hillman Canc Ctr, Melanoma Program, Pittsburgh, PA USA
[5] Natl Canc Inst, CTEP, Bethesda, MD USA
[6] Jonsson Comprehens Canc Ctr UCLA, Dept Med, Los Angeles, CA USA
[7] Univ Utah Hlth Canc Hosp, Oncol Dept, Salt Lake City, UT USA
关键词
D O I
10.1016/j.annonc.2021.08.1458
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1073P
引用
收藏
页码:S890 / S890
页数:1
相关论文
共 50 条
  • [1] SWOG S1404: A phase III randomized trial comparing standard of care adjuvant therapy to pembrolizumab in patients with high risk resected melanoma.
    Grossmann, Kenneth F.
    Othus, Megan
    Tarhini, Ahmad A.
    Patel, Sapna Pradyuman
    Moon, James
    Sondak, Vernon K.
    Kirkwood, John M.
    Ribas, Antoni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Role of Adjuvant Regional Nodal Irradiation in Resected Melanoma: A Secondary Analysis of SWOG S1404
    Bhandari, M.
    Othus, M.
    Kirkwood, J.
    Sondak, V.
    Ahmad, T.
    Sharon, E.
    Grossmann, K.
    Ribas, A.
    Patel, S.
    Wuthrick, E. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S82 - S83
  • [3] SWOG S1404: A phase III randomized trial comparing high dose interferon to pembrolizumab in patients with high risk resected melanoma.
    Grossmann, Kenneth F.
    Othus, Megan
    Tarhini, Ahmad A.
    Patel, Sapna Pradyuman
    Kirkwood, John M.
    Moon, James
    Sondak, Vernon K.
    Ribas, Antoni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial
    Unger, Joseph M.
    Darke, Amy
    Othus, Megan
    Truong, Thach-Giao
    Khushalani, Nikhil
    Kendra, Kari
    Lewis, Karl D.
    Faller, Bryan
    Funchain, Pauline
    Buchbinder, Elizabeth I.
    Tarhini, Ahmad A.
    Kirkwood, John M.
    Sharon, Elad
    Sondak, Vernon
    Guild, Samantha R.
    Grossmann, Kenneth
    Ribas, Antoni
    Patel, Sapna P.
    [J]. JAMA ONCOLOGY, 2023, 9 (02) : 251 - 260
  • [5] QUALITY OF LIFE (QOL) ASSESSMENT IN A PHASE I TRIAL OF NONI
    Issell, Brian F.
    Gotay, Carolyn C.
    Pagano, Ian
    [J]. QUALITY OF LIFE RESEARCH, 2005, 14 (09) : 2048 - 2048
  • [6] Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma.
    Grossmann, Kenneth F.
    Othus, Megan
    Patel, Sapna Pradyuman
    Tarhini, Ahmad A.
    Sondak, Vernon K.
    Petrella, Teresa M.
    Truong, Thach-Giao
    Khushalani, Nikhil I.
    Cohen, Justine Vanessa
    Buchbinder, Elizabeth Iannotti
    Kendra, Kari Lynn
    Funchain, Pauline
    Lewis, Karl D.
    Chmielowski, Bartosz
    Li, Hongli
    Moon, James
    Gunturu, Krishna Soujanya
    Eroglu, Zeynep
    Kirkwood, John M.
    Ribas, Antoni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Systematic review of quality of life (QoL) inclusion among endpoints, reporting and impact of QoL results in phase III non-inferiority trials of systemic treatments in oncology
    Paparo, J.
    Zumstein, L.
    Notarnicola, S.
    Marandino, L.
    Perrone, F.
    Di Maio, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S950 - S951
  • [9] LONGITUDINAL ANALYSIS OF QUALITY OF LIFE (QOL) WITHIN A RANDOMIZED PHASE III TRIAL IN PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA (MPA)
    Bonnetain, F.
    Maillard, E.
    Seitz, J.
    Mitry, E.
    Ychou, M.
    Gasmi, M.
    Raoul, J.
    Mariette, C.
    Bedenne, L.
    Dahan, L.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 28 - 28
  • [10] Assessment of quality of life (QOL) in phase III trials in advanced colorectal cancer (CRC).
    Adamowicz, K.
    Jassem, J.
    Saad, E. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)